Literature DB >> 30430749

A Two-Step Multicomponent Synthetic Approach and Anti-inflammatory Evaluation of N-Substituted 2-Oxopyrazines.

Eduardo Hernández-Vázquez1, Alejandra Chávez-Riveros1, Antonio Nieto-Camacho1, Luis D Miranda1.   

Abstract

Inflammation is widely reported as a main factor for the development of chronic diseases such as cancer, diabetes, and even metabolic syndrome. Thus, the search for novel anti-inflammatory compounds is required. Herein we describe the synthesis of a collection of peptidic pyrazinones by a convenient approach involving a multicomponent isocyanide-based reaction followed by a tandem deprotection/oxidative cyclization step. This series of compounds were tested for their potential anti-inflammatory capacity in an in vivo murine model, and four compounds were identified to inhibit tetradecanoylphorbol acetate (TPA)-induced edema by more than 75 %. The two most active compounds, N-benzyl-2-(4-hydroxy-3,5-dimethoxyphenyl)-2-[2-oxopyrazin-1(2H)-yl]acetamide (10 o) and N-cyclohexyl-2-[2-oxopyrazin-1(2H)-yl]-2-[4-(trifluoromethyl)phenyl]acetamide (10 x), with methyl and trifluoromethyl groups, were also able to decrease myeloperoxidase activity and leukocyte infiltration. Moreover, 10 x decreased the thickness of TPA-treated mouse ears, as observed in histological analysis of the tissues.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  edema; inflammation; multicomponent reactions; nitrogen heterocycles; peptides

Mesh:

Substances:

Year:  2018        PMID: 30430749     DOI: 10.1002/cmdc.201800634

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  2 in total

Review 1.  Two decades of recent advances of Ugi reactions: synthetic and pharmaceutical applications.

Authors:  Manar Ahmed Fouad; Hamida Abdel-Hamid; Mohammed Salah Ayoup
Journal:  RSC Adv       Date:  2020-11-23       Impact factor: 4.036

2.  Discovery of Benzopyrrolizidines as Promising Antigiardiasic Agents.

Authors:  Juan Carlos Auriostigue-Bautista; Eduardo Hernández-Vázquez; David González-Calderón; Jorge Luís Figueroa-Romero; Adriana Castillo-Villanueva; Angélica Torres-Arroyo; Martha Ponce-Macotela; Yadira Rufino-González; Mario Martínez-Gordillo; Luis D Miranda; Jesús Oria-Hernández; Horacio Reyes-Vivas
Journal:  Front Cell Infect Microbiol       Date:  2022-01-12       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.